NCT02106572View on ClinicalTrials.gov

Therapeutic Instillation of Mistletoe

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

548

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
Superficial Bladder Cancer
Interventions
DRUG

abnobaVISCUM 900

intravesical instillation of abnobaVISCUM 900 13 times during treatment period

DRUG

Mitomycin C

intravesical instillation of Mitomycin C 10 times during treatment period

Trial Locations (5)

12411

Theodor Bilharz Research Institute, Giza

37412

Urologische Praxis, Herzberg

45122

Clinic of Urology of the University Hospital of Essen, Essen

52146

Urologische Facharztpraxis, Würselen

52525

Urologische Gemeinschaftspraxis, Heinsberg

Sponsors

Lead Sponsor

Abnoba Gmbh
All Listed Sponsors
lead

Abnoba Gmbh

INDUSTRY

NCT02106572 - Therapeutic Instillation of Mistletoe | Biotech Hunter | Biotech Hunter